A recent study in discusses how gut inflammation is associated with age and Alzheimer’s disease.
Arrowhead spotlights key pancreatitis figures from Phase 3 lipid disease study to differentiate itself from Ionis
Arrowhead Pharmaceuticals has unveiled highly anticipated pancreatitis results from a late-phase trial of plozasiran for a rare lipid disorder, several months after reporting topline data